Institut Paoli-Calmettes: Breast Neoplasms trials
The registry lists 22 Breast Neoplasms studies with Institut Paoli-Calmettes as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 1 5Phase 2 6Phase 3 3No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2- Advanced Breast CancersNot yet recruitingNCT05986071Phase 1/2
- A Phase 1b/2 Trial Evaluating Safety and Efficacy of CAPecitabine in Combination With Ni-rapaRIb in HER2-negative Advanced Breast canCErNot yet recruitingNCT05519670Phase 1/2
- Real Time Molecular Analysis of Breast Cancer Receiving Neo-adjuvant ChemotherapyRecruitingNCT04504747
- Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene MutationRecruitingNCT03667417
- Database of Data CollectionRecruitingNCT03461172
- Institut Paoli Calmettes Breast Cancer DatabaseRecruitingNCT02869607
- Trans-RosaLEE Study: a Biomarker-directed, Translational StudyActive, not recruitingNCT05529862Not applicable
- A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid TumorsActive, not recruitingNCT05143970Phase 1
- Feasibility Study of an Adapted and Supported Water Polo Program to Reduce Fatigue Related to Cancer and Improve Psychological and Social Recovery in Patients With Breast Cancer RemissionStatus unknownNCT04235946Not applicable
- Eribulin in Brain Metastases From HER2-negative Breast CancerWithdrawnNCT03637868Phase 2
- Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell TransplantationCompletedNCT02860585
- Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After TreatmentTerminatedNCT02525211Phase 3
- Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast CancerTerminatedNCT01980277Phase 1/2
- Evaluation of the Efficacy of Hippocampal Avoidance on the Cognitive Toxicity of Whole-Brain Radiation Therapy After Surgical Resection of Single Brain Metastasis of Breast CancerCompletedNCT01942980Phase 3
- Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph NodeActive, not recruitingNCT01717131Not applicable
- Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast CancerTerminatedNCT01589861Phase 1/2
- Predictive Clinical and Biological Parameters in Breast CancerTerminatedNCT01521676Not applicable
- Triple Negative Breast Cancer: Study of Molecular and Genetic FactorsStatus unknownNCT01434420Not applicable
- Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab and Chemotherapy in Breast CancerCompletedNCT01190345Phase 2
- Personalised Program for Women Treated for Hodgkin DiseaseTerminatedNCT01188915Not applicable
- Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate CancerCompletedNCT00925418Phase 3
- Utilization of Genomic Signature as Decision-making for Adjuvant Treatment of Breast CancerStatus unknownNCT00912080Not applicable